Literature DB >> 24051159

DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.

Xiaozhe Han1, Karen B LaRosa2, Toshihisa Kawai2, Martin A Taubman2.   

Abstract

BACKGROUND: Porphyromonas gingivalis (Pg) is one of a constellation of oral organisms associated with human chronic periodontitis. While adaptive immunity to periodontal pathogen proteins has been investigated and is an important component of periodontal bone resorption, the effect of periodontal pathogen DNA in eliciting systemic and mucosal antibody and modulating immune responses has not been investigated.
METHODS: Rowett rats were locally injected with whole genomic Pg DNA in alum. Escherichia coli (Ec) genomic DNA, Fusobacterium nucleatum (Fn) genomic DNA, and saline/alum injected rats served as controls. After various time points, serum IgG and salivary IgA antibody to Ec, Fn or Pg were detected by ELISA. Serum and salivary antibody reactions with Pg surface antigens were determined by Western blot analyses and the specific antigen was identified by mass spectrometry. Effects of genomic DNA immunization on Pg bacterial colonization and experimental periodontal bone resorption were also evaluated.
RESULTS: Sera from Pg DNA, Ec DNA and Fn DNA-injected rats did not react with Ec or Fn bacteria. Serum IgG antibody levels to Pg and Pg surface extracts were significantly higher in animals immunized with Pg DNA as compared to the control groups. Rats injected with Pg DNA demonstrated a strong serum IgG and salivary IgA antibody reaction solely to Pg fimbrillin (41kDa), the major protein component of Pg fimbriae. In the Pg DNA-immunized group, the numbers of Pg bacteria in oral cavity and the extent of periodontal bone resorption were significantly reduced after Pg infection.
CONCLUSIONS: This study suggests that infected hosts may select specific genes from whole genomic DNA of the periodontal pathogen for transcription and presentation. The results indicate that the unique gene selected can initiate a host protective immune response to the parent bacterium.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  APCs; Bacterial genomic DNA; Bone resorption; ELISA; Ec; Escherichia coli; Fn; Fusobacterium nucleatum; Immune response; LPS; MS; Periodontal disease; Pg; Porphyromonas gingivalis; Vaccine; antigen presenting cells; enzyme-linked immunosorbent assay; lipopolysaccharide; mass spectrometry

Mesh:

Substances:

Year:  2013        PMID: 24051159      PMCID: PMC3872268          DOI: 10.1016/j.vaccine.2013.09.004

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  34 in total

1.  Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice.

Authors:  S Kawabata; Y Terao; T Fujiwara; I Nakagawa; S Hamada
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules.

Authors:  S K Eo; M Gierynska; A A Kamar; B T Rouse
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

3.  Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg.

Authors:  Xiao-Wen He; Fang Wang; Lei Jiang; Jun Li; Shan-Kui Liu; Zhen-Yu Xiao; Xiao-Qin Jin; Ya-Nan Zhang; Ying He; Kai Li; Ying-Jun Guo; Shu-Han Sun
Journal:  J Gen Virol       Date:  2005-03       Impact factor: 3.891

4.  B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.

Authors:  Toshihisa Kawai; Takashi Matsuyama; Yoshitaka Hosokawa; Seicho Makihira; Makoto Seki; Nadeem Y Karimbux; Reginaldo B Goncalves; Paloma Valverde; Serge Dibart; Yi-Ping Li; Leticia A Miranda; Cory W O Ernst; Yuichi Izumi; Martin A Taubman
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

5.  Arg-gingipain a DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model.

Authors:  H Yonezawa; K Ishihara; K Okuda
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection.

Authors:  M Kuboniwa; A Amano; S Shizukuishi; I Nakagawa; S Hamada
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Regulation of the Porphyromonas gingivalis fimA (Fimbrillin) gene.

Authors:  H Xie; W O Chung; Y Park; R J Lamont
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Immunization by Arg-gingipain A DNA vaccine protects mice against an invasive Porphyromonas gingivalis infection through regulation of interferon-gamma production.

Authors:  H Yonezawa; T Kato; H K Kuramitsu; K Okuda; K Ishihara
Journal:  Oral Microbiol Immunol       Date:  2005-10

9.  Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid.

Authors:  J W Eastcott; C J Holmberg; F E Dewhirst; T R Esch; D J Smith; M A Taubman
Journal:  Vaccine       Date:  2001-02-08       Impact factor: 3.641

10.  Involvement of minor components associated with the FimA fimbriae of Porphyromonas gingivalis in adhesive functions.

Authors:  So-Ichiro Nishiyama; Yukitaka Murakami; Hideki Nagata; Satoshi Shizukuishi; Ikuro Kawagishi; Fuminobu Yoshimura
Journal:  Microbiology (Reading)       Date:  2007-06       Impact factor: 2.777

View more
  6 in total

Review 1.  Microbial Nucleic Acid Sensing in Oral and Systemic Diseases.

Authors:  K E Crump; S E Sahingur
Journal:  J Dent Res       Date:  2015-10-05       Impact factor: 6.116

2.  Distinctive pathways characterize A. actinomycetemcomitans and P. gingivalis.

Authors:  Jing Lv; Yi-Xin Zhu; Ying-Qun Liu; Xin Xue
Journal:  Mol Biol Rep       Date:  2014-10-29       Impact factor: 2.316

3.  Comparison of Experimental Diabetic Periodontitis Induced by Porphyromonas gingivalis in Mice.

Authors:  Qi Wang; Peng Zhang; Ray Aprecio; Dongjiao Zhang; Hao Li; Ning Ji; Omaima Mohamed; Wu Zhang; Yiming Li; Yi Ding
Journal:  J Diabetes Res       Date:  2016-11-23       Impact factor: 4.011

4.  Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics.

Authors:  Sajjad Ahmad; Afifa Navid; Rabia Farid; Ghulam Abbas; Faisal Ahmad; Naila Zaman; Nousheen Parvaiz; Syed Sikander Azam
Journal:  Eur J Pharm Sci       Date:  2020-05-23       Impact factor: 4.384

5.  Immunization with cell-free-generated vaccine protects from Porphyromonas gingivalis-induced alveolar bone loss.

Authors:  Nasi Huang; Elyse Shimomura; Gang Yin; Cuong Tran; Aaron Sato; Alex Steiner; Tyler Heibeck; Michelle Tam; Jeffery Fairman; Frank C Gibson
Journal:  J Clin Periodontol       Date:  2019-01-31       Impact factor: 8.728

6.  Computational Design of a Multi-Epitope Vaccine Against Porphyromonas gingivalis.

Authors:  Bilal Shaker; Sajjad Ahmad; Junhao Shen; Hyung Wook Kim; Dokyun Na
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.